The first study in the world to take a detailed look at scar tissue in human pancreatic cancer has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.
Each year around 9,800 people in the UK are diagnosed with pancreatic cancer. Scar tissue is a particular problem in the disease, where it forms the largest proportion of tumour volume out of any type of cancer.
The intense scar tissue forms a protective wall around the cancer, hampering treatments including chemotherapy, immunotherapy or radiotherapy. This contributes to it being a particularly aggressive disease, with the lowest survival rate of all cancers - fewer than five per cent of patients survive for five years or more.
For more information, visit: Eurekalert
Queen Mary University of London is a public research university in London, England.
Read more related topics: